112 related articles for article (PubMed ID: 17348637)
1. Cinnamoyl compounds as simple molecules that inhibit p300 histone acetyltransferase.
Costi R; Di Santo R; Artico M; Miele G; Valentini P; Novellino E; Cereseto A
J Med Chem; 2007 Apr; 50(8):1973-7. PubMed ID: 17348637
[TBL] [Abstract][Full Text] [Related]
2. Regulation of histone acetylation and nucleosome assembly by transcription factor JDP2.
Jin C; Kato K; Chimura T; Yamasaki T; Nakade K; Murata T; Li H; Pan J; Zhao M; Sun K; Chiu R; Ito T; Nagata K; Horikoshi M; Yokoyama KK
Nat Struct Mol Biol; 2006 Apr; 13(4):331-8. PubMed ID: 16518400
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of p300-HAT alters global gene expression and represses HIV replication.
Mantelingu K; Reddy BA; Swaminathan V; Kishore AH; Siddappa NB; Kumar GV; Nagashankar G; Natesh N; Roy S; Sadhale PP; Ranga U; Narayana C; Kundu TK
Chem Biol; 2007 Jun; 14(6):645-57. PubMed ID: 17584612
[TBL] [Abstract][Full Text] [Related]
4. Histone acetyltransferase p300 regulates the transcription of human erythroid-specific 5-aminolevulinate synthase gene.
Han L; Lu J; Pan L; Wang X; Shao Y; Han S; Huang B
Biochem Biophys Res Commun; 2006 Sep; 348(3):799-806. PubMed ID: 16904069
[TBL] [Abstract][Full Text] [Related]
5. Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK.
Ko SI; Lee IS; Kim JY; Kim SM; Kim DW; Lee KS; Woo KM; Baek JH; Choo JK; Seo SB
FEBS Lett; 2006 May; 580(13):3217-22. PubMed ID: 16696975
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of polymerase II transcription repression by the histone variant macroH2A.
Doyen CM; An W; Angelov D; Bondarenko V; Mietton F; Studitsky VM; Hamiche A; Roeder RG; Bouvet P; Dimitrov S
Mol Cell Biol; 2006 Feb; 26(3):1156-64. PubMed ID: 16428466
[TBL] [Abstract][Full Text] [Related]
7. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-mediated histone hyperacetylation in oral cancer: target for a water-soluble HAT inhibitor, CTK7A.
Arif M; Vedamurthy BM; Choudhari R; Ostwal YB; Mantelingu K; Kodaganur GS; Kundu TK
Chem Biol; 2010 Aug; 17(8):903-13. PubMed ID: 20797619
[TBL] [Abstract][Full Text] [Related]
9. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration.
Rouaux C; Jokic N; Mbebi C; Boutillier S; Loeffler JP; Boutillier AL
EMBO J; 2003 Dec; 22(24):6537-49. PubMed ID: 14657026
[TBL] [Abstract][Full Text] [Related]
10. Activation of p300 histone acetyltransferase by small molecules altering enzyme structure: probed by surface-enhanced Raman spectroscopy.
Mantelingu K; Kishore AH; Balasubramanyam K; Kumar GV; Altaf M; Swamy SN; Selvi R; Das C; Narayana C; Rangappa KS; Kundu TK
J Phys Chem B; 2007 May; 111(17):4527-34. PubMed ID: 17417897
[TBL] [Abstract][Full Text] [Related]
11. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.
Mai A; Rotili D; Tarantino D; Nebbioso A; Castellano S; Sbardella G; Tini M; Altucci L
Bioorg Med Chem Lett; 2009 Feb; 19(4):1132-5. PubMed ID: 19144517
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of CBP/p300 HAT.
Sarli V; Giannis A
Chem Biol; 2007 Jun; 14(6):605-6. PubMed ID: 17584607
[TBL] [Abstract][Full Text] [Related]
13. Curcumin is an inhibitor of p300 histone acetylatransferase.
Marcu MG; Jung YJ; Lee S; Chung EJ; Lee MJ; Trepel J; Neckers L
Med Chem; 2006 Mar; 2(2):169-74. PubMed ID: 16787365
[TBL] [Abstract][Full Text] [Related]
14. A mechanism for coordinating chromatin modification and preinitiation complex assembly.
Black JC; Choi JE; Lombardo SR; Carey M
Mol Cell; 2006 Sep; 23(6):809-18. PubMed ID: 16973433
[TBL] [Abstract][Full Text] [Related]
15. Small molecule modulators of histone acetyltransferase p300.
Balasubramanyam K; Swaminathan V; Ranganathan A; Kundu TK
J Biol Chem; 2003 May; 278(21):19134-40. PubMed ID: 12624111
[TBL] [Abstract][Full Text] [Related]
16. Structure-Activity Relationships on Cinnamoyl Derivatives as Inhibitors of p300 Histone Acetyltransferase.
Madia VN; Benedetti R; Barreca ML; Ngo L; Pescatori L; Messore A; Pupo G; Saccoliti F; Valente S; Mai A; Scipione L; Zheng YG; Tintori C; Botta M; Cecchetti V; Altucci L; Di Santo R; Costi R
ChemMedChem; 2017 Aug; 12(16):1359-1368. PubMed ID: 28346821
[TBL] [Abstract][Full Text] [Related]
17. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity.
Stimson L; Rowlands MG; Newbatt YM; Smith NF; Raynaud FI; Rogers P; Bavetsias V; Gorsuch S; Jarman M; Bannister A; Kouzarides T; McDonald E; Workman P; Aherne GW
Mol Cancer Ther; 2005 Oct; 4(10):1521-32. PubMed ID: 16227401
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties.
Mai A; Rotili D; Tarantino D; Ornaghi P; Tosi F; Vicidomini C; Sbardella G; Nebbioso A; Miceli M; Altucci L; Filetici P
J Med Chem; 2006 Nov; 49(23):6897-907. PubMed ID: 17154519
[TBL] [Abstract][Full Text] [Related]
19. Analysis of p300 acetyltransferase substrate specificity by MALDI TOF mass spectrometry.
Dormeyer W; Ott M; Schnölzer M
Methods; 2005 Aug; 36(4):376-82. PubMed ID: 16085422
[TBL] [Abstract][Full Text] [Related]
20. Autoacetylation induced specific structural changes in histone acetyltransferase domain of p300: probed by surface enhanced Raman spectroscopy.
Arif M; Kumar GV; Narayana C; Kundu TK
J Phys Chem B; 2007 Oct; 111(41):11877-9. PubMed ID: 17894486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
